Literature DB >> 27889352

Oxidized glutathione and uric acid as biomarkers of early cystic fibrosis lung disease.

Nina Dickerhof1, Rufus Turner2, Irada Khalilova2, Emmanuelle Fantino3, Peter D Sly3, Anthony J Kettle2.   

Abstract

BACKGROUND: In cystic fibrosis (CF) there is an urgent need for earlier diagnosis of pulmonary infections and inflammation using blood- and urine-based biomarkers.
METHODS: Using mass spectrometry, oxidation products of glutathione and uric acid were measured in matched samples of bronchoalveolar lavage (BAL), serum and urine from 36 infants and children with CF, and related to markers of neutrophilic inflammation and infection in BAL.
RESULTS: Oxidation products of glutathione (glutathione sulfonamide, GSA) and uric acid (allantoin), were elevated in BAL of children with pulmonary infections with Pseudomonas aeruginosa (PsA) compared to those without (p<0.05) and correlated with other markers of neutrophilic inflammation. Serum GSA was significantly elevated in children with PsA infections (p<0.01). Urinary GSA correlated with pulmonary GSA (r=0.42, p<0.05) and markers of neutrophilic inflammation.
CONCLUSIONS: This proof-of-concept study demonstrates that urinary GSA but not allantoin shows promise as a non-invasive marker of neutrophilic inflammation in early CF lung disease.
Copyright © 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allantoin; Glutathione sulfonamide; Myeloperoxidase; Neutrophil; Neutrophil elastase; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2016        PMID: 27889352     DOI: 10.1016/j.jcf.2016.10.012

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  8 in total

Review 1.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

2.  Urinary metabolomics reveals unique metabolic signatures in infants with cystic fibrosis.

Authors:  B T Kopp; E Joseloff; D Goetz; B Ingram; S L Heltshe; D H Leung; B W Ramsey; K McCoy; D Borowitz
Journal:  J Cyst Fibros       Date:  2018-11-23       Impact factor: 5.482

3.  Links between Disease Severity, Bacterial Infections and Oxidative Stress in Cystic Fibrosis.

Authors:  Sabina Galiniak; Mateusz Mołoń; Marta Rachel
Journal:  Antioxidants (Basel)       Date:  2022-04-29

4.  Conjugation of urate-derived electrophiles to proteins during normal metabolism and inflammation.

Authors:  Rufus Turner; Stephen O Brennan; Louisa V Ashby; Nina Dickerhof; Melanie R Hamzah; John F Pearson; Lisa K Stamp; Anthony J Kettle
Journal:  J Biol Chem       Date:  2018-11-01       Impact factor: 5.157

5.  Association of serum uric acid levels with COVID-19 severity.

Authors:  Fang Hu; Yifan Guo; Jianghong Lin; Yingjuan Zeng; Juan Wang; Man Li; Li Cong
Journal:  BMC Endocr Disord       Date:  2021-05-08       Impact factor: 2.763

Review 6.  Role of inflammation and oxidative stress in tissue damage associated with cystic fibrosis: CAPE as a future therapeutic strategy.

Authors:  Victor Emanuel Miranda Soares; Thiago Inácio Teixeira do Carmo; Fernanda Dos Anjos; Jonatha Wruck; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini; Débora Tavares de Resende E Silva
Journal:  Mol Cell Biochem       Date:  2021-09-16       Impact factor: 3.396

7.  Uric acid disrupts hypochlorous acid production and the bactericidal activity of HL-60 cells.

Authors:  Larissa A C Carvalho; João P P B Lopes; Gilberto H Kaihami; Railmara P Silva; Alexandre Bruni-Cardoso; Regina L Baldini; Flavia C Meotti
Journal:  Redox Biol       Date:  2018-03-01       Impact factor: 11.799

8.  Transcriptome analysis of tumor-derived mesenchymal progenitor cells shows that CHST15 is a fibrosis regulator of retroperitoneal liposarcoma.

Authors:  Yang Sun; Fengjun Xiao; Huiyan Sun; Lin Zhang; Weida Chen; Li Du; Chengfeng Sun; Weiyuan Zhang; Qinqin Xu; Chengli Miao; Lisheng Wang
Journal:  Ann Transl Med       Date:  2022-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.